New research from Dost Ongur and colleagues, first author Lauren V. Moran suggests that patients taking a high dose of a prescription amphetamine face more than a five-fold increased risk for developing psychosis or mania.

Boston Children's Hospital Answers article on new research from Joseph Gonzalez-Heydrich, David Glahn, and colleagues, co-first authors Catherine Brownstein and Elise Douard (Université de Montréal) finding that children with early-onset psychosis have similar rates of deleterious copy number variants (CNVs) as children diagnosed with autism spectrum disorder. The new study suggests that all children and adolescents with a psychotic diagnosis might benefit from undergoing genetic screening.